Sign Out
Anagrelide Capsules 0.5 mg is indicated for the reduction of elevated platelet counts in at risk essential thrombocythemia (ET) patients who are intolerant to their current therapy or whose elevated platelet counts are not reduced to an acceptable level by their current therapy.
An at risk essential thrombocythemia patient is defined by one or more of the following features: >60 years of age or; a platelet count >1000 X 109/L or; a history of thrombo-haemorrhagic events.
Or as prescribed by the physician.
Continue with Google